While decent work has emerged as the central theme of the psychology of work theory and a global concept and directive for promoting social, political, and economic justice, it has garnered increasing scientific and political attention in the past two decades. However, until now, no defined measurement scale for the pharmaceutical supply chain exists. The present study aims to design and validate key performance indicators (KPIs) for 'decent work' in the pharmaceutical industry supply chain of Iran, using the Decent Work Daffi Scale (2017) as a reliable framework with five sub-scales and 15 items, tested and validated. For the validation of the Decent Work Scale, a quantitative survey study was conducted among selected pharmaceutical industry experts with a sample size of 228 individuals in the year 2023. The current study adopted an exploratory factor analysis approach using SPSS software and a confirmatory factor analysis through AMOS version 24 software. In this context, the factor structure, convergent validity, discriminant validity, and Cronbach's alpha coefficients were examined. The results showed that the five-factor structure outperforms the one-factor model with evidence supporting the convergent, discriminant, and predictive validity of the five-factor scale. Thus, the measurement of decent work in the pharmaceutical industry of Iran comprises five sub-scales: occupational safety conditions, access to healthcare, adequate remuneration, Free time and rest, and alignment of organizational values with family and societal values. This scale can serve as a useful tool for industrial and organizational psychology research, as well as for studies on the sustainability of social supply chains.

In the current pharmaceutical context of Jordan, the significance of Business Intelligence (BI) has emerged as a crucial factor in designing efficient planning methods. This research investigates the transformative impact of business intelligence (BI) in four key domains: drug development enhancement, operational optimization, compliance assurance, and market dynamics comprehension. The research highlights the need to utilize a data-driven methodology to emphasize the value of business intelligence (BI) tools in extracting valuable insights, facilitating strategic decision-making, and promoting operational efficiency. The results indicate that pharmaceutical organizations that utilize business intelligence (BI) can uncover concealed patterns, recognize chances for growth, and make well-informed decisions. Additionally, the capacity of business intelligence (BI) to integrate novel data has accelerated the development of resilient technical frameworks, thereby reinforcing its essential position within the pharmaceutical sector in Jordan. This research serves as evidence of the potential of business intelligence (BI) in facilitating innovation, surmounting obstacles, and eventually improving patient outcomes.

This research came to examine the influence of green supply chain practices on export performance. The research population consists of the decision-makers in pharmaceutical companies in Jordan. The Jordanian pharmaceutical industry is considered one of the oldest industrial sectors in the Arab region. Accordingly, the research took a purposive sampling method to collect primary data. The questionnaire was designed electronically via Google Forms and distributed to the study sample via e-mail. Data were analyzed using covariance-based structural equation modeling (CB-SEM) by version 24 of AMOS software. The study results showed that green supply chain dimensions have influenced export performance of the pharmaceutical industry in Jordan. Based on the study results, the researchers recommend managers and decision makers of the pharmaceutical organizations to create a policy outlining the organization's commitment to sustainability and outlining its aims and objectives for decreasing its environmental effect.

This study came with the aim of identifying the impact of the green supply chain on sustainability. This research targeted managers at the senior and middle levels of the Pharmaceutical Industry in Jordan, as they were formulating the company's strategies and determining its policies. A purposive sample consisting of 258 managers was selected. To gather the data needed for the analysis, a self-report questionnaire was used formulated electronically through Google Forms. AMOS software was used to examine the research hypotheses. The study concluded that there was an impact of the green supply chain with its dimensions (Eco-Design, Green Distribution, Green Purchasing, Green Manufacturing, and Green Reverse Logistics) on sustainability. Based on this result, the researcher recommends pharmaceutical companies in Jordan to take green initiatives and the trends towards implementing a green supply chain approach that reduces the consumption of non-renewable resources and waste, and to establish special laws and regulations in the company that oblige employees to apply the green approach in their practices within the work.

This paper evaluates the efficiency of five Indian pharmaceutical Industries using Data Envelopment Analysis (DEA) approach. The paper uses Net Block, Cash and Bank Balance, Share Capital, Reserve and Surplus, Secure Loan and Unsecured Loan as input variables and Investments and ‘Loans and Advances’ as output variables. In this study, the Basic Radial Models input oriented with Constant Returns to scale (CRS) are used to estimate the efficiency of pharmaceutical Industries. The DEA tool assists the administrators to identify the inefficient measures and take necessary actions for improvement. The results are indicative of the scenario that changed patent laws in India are not detrimental to the financial and overall health of Indian pharmaceutical companies in general. The Indian pharmaceutical companies have suitably modified their business model to cope up with the changed legal environment. It is a positive sign for all Indian pharmaceutical companies that they are dynamic in management and operational policies to face any new situation and shall flourish more in the coming days.

Recent technological advancements are endless and have had a profound influence on everyone in every part of life throughout the preceding decades. Artificial intelligence is one such invention that has the potential to change the world. Now, artificial intelligence is being used in almost all commercial operations. Hence, this research attempted to investigate the impact of artificial intelligence dimensions, including natural language processing, machine learning, expert systems, and computer vision on the financial decisions of pharmaceutical companies in Jordan. A cross-sectional approach was used through a comprehensive survey to collect research data from 148 accountants and financial managers in pharmaceutical companies listed on the Amman Stock Exchange with a response rate of 81.3%. The research hypotheses were examined using structural equation modeling of the collected quantitative data. The results indicated that the dimensions of artificial intelligence positively impact financial decisions. Accordingly, companies should spend on building strong artificial intelligence infrastructure and skills. Access to modern artificial intelligence technology, data analysis tools and cloud computing resources are also essential to rationalizing financial decision-making. Besides, Jordan's pharmaceutical sector can overcome these limitations and realize the full potential of artificial intelligence in financial decision-making by solving data privacy issues, encouraging ethical AI re-search, investing in artificial intelligence expertise, and enhancing collaboration.

This study aims to contribute to the literature on organizational sustainability and explore the issues, challenges, and prospects of the Bangladesh pharmaceutical industry in terms of sustainability. Organizations around the world are becoming more and more concerned about their ability to reduce or prevent the adverse effects of their actions. Sustainability, socially responsible human resource management (SRHRM), green human resource management (GHRM), characteristics of stakeholders, voluntary green behavior, innovative behavior, and government roles are the main areas of concern. Research and existing literature are explored to have a clear grasp of several organizational sustainability components. This study also shows how organizations understand and implement organizational sustainability concerns and difficulties and how to identify whether essential systemic components are still unaddressed. It's difficult to balance social, economic, and environmental responsibility with sustainability. Enhance SRHRM and GHRM by examining stakeholder characteristics and the government's involvement, combined with voluntary green and creative behavior, to create a positive image for society, the economy, and the environment. This research explores the issues, challenges, and prospects of Bangladesh's pharmaceutical industry's organizational sustainability. In contrast to the age of industry 4.0, artificial intelligence and machine learning concerns about human resource management, stakeholder characteristics, government role, and employee behavior contribute to the organizational sustainability of the pharmaceutical sector. The study presents first insights on the issues, challenges, and prospects of Bangladesh's pharmaceutical industry from the perspective of organizational sustainability. Sustainability, employee green and innovative behavior, SRHRM, GHRM, stakeholder characteristics, and government roles are drawing the attention of organizations globally. They are taking more and more responsibility for how their actions affect the environment, society, and the economy.